Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Primary ovarian insufficiency

Obstetrics and gynaecology · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Recognise associated adrenal failure

POI with vomiting, abdominal pain, hypotension, hypoglycaemia, hyponatraemia, hyperkalaemia or hyperpigmentation may be part of autoimmune adrenal insufficiency and can progress to adrenal crisis.

Action: Check observations, glucose, electrolytes and cortisol without delaying emergency hydrocortisone and fluid treatment when adrenal crisis is clinically suspected, then involve endocrinology urgently.

Synopsis

Confirm primary ovarian insufficiency before age 40, investigate genetic and autoimmune causes sensitively, replace sex steroids safely, and address bone, cardiovascular, fertility and psychological consequences.

  • POI means loss or marked fluctuation of ovarian activity before age 40, presenting with irregular or absent cycles, oestrogen-deficiency symptoms or infertility; it is not synonymous with irreversible zero ovarian function.
  • Exclude pregnancy and treatment effects. Current NICE NG23 diagnoses POI from symptoms and elevated FSH on two samples four to six weeks apart, and advises against diagnosis from one test or routine AMH.
  • The newer 2025 international guideline uses at least four months of disordered cycles plus FSH above 25 IU/L, repeating FSH only if uncertainty remains; follow the current NHS or specialist pathway and document which criterion is applied.
  • For non-iatrogenic POI, specialist assessment commonly includes chromosomal analysis, FMR1 premutation testing with genetic counselling, TSH and 21-hydroxylase antibodies when the cause is unknown.
  • Offer sex-steroid replacement with HRT or an eligible combined hormonal contraceptive and continue until at least the usual age of natural menopause unless contraindicated; protect the endometrium whenever a uterus is present.
  • HRT is not contraception. Intermittent ovulation and occasional spontaneous conception can occur, so discuss pregnancy testing, contraception and fertility goals explicitly.
  • Assess bone health with DXA at diagnosis under current international guidance, support adequate calcium, vitamin D and weight-bearing activity, and avoid substituting supplements for adequate oestrogen replacement.
  • No treatment reliably restores depleted ovarian activity; reproductive-medicine discussion includes unpredictable spontaneous ovulation, donor-oocyte conception and options shaped by age, previous treatment and personal values.

Key red flags

Collapse, hypotension, recurrent vomiting, abdominal pain, hypoglycaemia or electrolyte disturbance with autoimmune features requires urgent assessment for adrenal crisis.

A positive pregnancy test with pain or bleeding still requires ectopic-pregnancy assessment because intermittent ovulation can occur after a POI diagnosis.

Short stature, webbed neck, lymphoedema history, cardiac signs or a Turner-pattern karyotype requires specialist cardiovascular and aortic assessment before pregnancy treatment.

New neurological symptoms, galactorrhoea or low rather than raised gonadotrophins should trigger diagnostic reconsideration for central disease.

Severe distress, suicidal thoughts or acute crisis after an unexpected fertility diagnosis needs urgent psychological or mental-health support.

Investigation priorities

01
Pregnancy test and repeated FSHFirst step

Exclude pregnancy and biochemically confirm the UK NICE diagnosis in a person under 40.

Management branches

ConfirmationApply an explicit diagnostic standard

A person younger than 40 has disordered cycles or oestrogen-deficiency symptoms.

  1. Exclude pregnancy, document at least the relevant duration of cycle change and review contraception, HRT, surgery and gonadotoxic treatment.
  2. Under NICE, demonstrate raised FSH twice four to six weeks apart with compatible symptoms; refer when results or treatment effects make classification uncertain.
  3. Explain the diagnosis sensitively and arrange early symptom, fertility, bone and cardiovascular care rather than waiting for every causal test.

Key medicines

Transdermal 17β-oestradiolUse a physiological replacement regimen, commonly a 100 microgram/24-hour patch changed twice weekly, with dose adjusted by symptoms, tolerability and specialist goals until natural-menopause age.Add adequate progestogen with an intact uterus; review unexplained bleeding, hormone-sensitive cancer, thrombosis and liver disease, while recognising transdermal oestradiol has lower thrombotic impact than oral therapy.
Micronised progesteroneWith cyclic oestradiol, a common regimen is 200 mg orally at bedtime for 12–14 days of each 28-day cycle; a continuous regimen may use 100 mg nightly after specialist review.Review sedation, dizziness and bleeding pattern, use adequate duration for the oestrogen dose, and investigate persistent or late-onset unscheduled bleeding rather than simply increasing courses.
Open full textbook →Answer 2 questions
Sources and review status5 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NICE NG23 menopause recommendations
  • British Menopause Society POI statement
  • International POI guideline 2025
  • NICE POI quality statement
  • NHS Genomics POI resource

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom